Cargando…
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis
Activation of the NOX4/NLRP3 inflammasome pathway has been associated with fibrosis in other organs. An imbalance in intestinal bacteria is an important driving factor of liver fibrosis through the liver-gut axis. This study aimed to explore whether the effect of ursolic acid (UA) on liver fibrosis...
Autores principales: | Nie, Yuan, Liu, Qi, Zhang, Wang, Wan, Yipeng, Huang, Chenkai, Zhu, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451456/ https://www.ncbi.nlm.nih.gov/pubmed/34530693 http://dx.doi.org/10.1080/19490976.2021.1972746 |
Ejemplares similares
-
Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways
por: Wan, Sizhe, et al.
Publicado: (2020) -
Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
por: Wan, Si-Zhe, et al.
Publicado: (2019) -
Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway
por: Gan, Dakai, et al.
Publicado: (2018) -
Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
por: Wan, Sizhe, et al.
Publicado: (2020) -
Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis
por: Zhang, Wang, et al.
Publicado: (2019)